265 related articles for article (PubMed ID: 15077571)
21. Is zinc concentration in pancreatic fluid a marker for pancreatic diseases?
Pungpapong S; Scolapio JS; Woodward TA; Wallace MB; Raimondo M
JOP; 2005 Sep; 6(5):425-30. PubMed ID: 16186663
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
[TBL] [Abstract][Full Text] [Related]
23. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.
Chung YW; Han DS; Park KH; Eun CS; Yoo KS; Park CK
Dis Colon Rectum; 2008 May; 51(5):593-7. PubMed ID: 18219529
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.
Gregg EW; Gu Q; Williams D; de Rekeneire N; Cheng YJ; Geiss L; Engelgau M
Diabetes Res Clin Pract; 2007 Sep; 77(3):485-8. PubMed ID: 17306411
[TBL] [Abstract][Full Text] [Related]
25. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
Sundborn G; Metcalf P; Scragg R; Schaaf D; Dyall L; Gentles D; Black P; Jackson R
N Z Med J; 2007 Jun; 120(1257):U2607. PubMed ID: 17632597
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of glucose metabolism profile in coronary disease. Prospective study in hospitalized patients.
Candeias R; Cacodecar S; Gomes V
Rev Port Cardiol; 2005 May; 24(5):703-11. PubMed ID: 16041966
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
28. [Pancreatic cancer--association with diabetes mellitus and smoking].
Díte P; Trna J; Belobrádková J; Novotný I; Hermanová M; Vlcková P; Klímová K; Kianicka B; Lemine A; Liberda M; Geryk E
Vnitr Lek; 2011 Feb; 57(2):159-62. PubMed ID: 21416856
[TBL] [Abstract][Full Text] [Related]
29. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
[TBL] [Abstract][Full Text] [Related]
30. [Glucose tolerance disorders in patients with cancer of the colon].
Muszyński J; Jóźwicka E; Szadkowski A; Stepka M
Pol Tyg Lek; 1990 Dec 3-10; 45(49-50):1005-7. PubMed ID: 2082319
[TBL] [Abstract][Full Text] [Related]
31. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.
Guo LX; Pan Q; Wang XX; Li H; Zhang LN; Chi JM; Wang Y
Chin Med J (Engl); 2008 Apr; 121(8):687-90. PubMed ID: 18701019
[TBL] [Abstract][Full Text] [Related]
32. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
Schiel R; Heinrich S; Steiner T; Ott U; Stein G
Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics of early-onset type 2 diabetes and risk factors associated with its chronic complications].
Zhang M; Li H; Zhang Z
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2547-51. PubMed ID: 17198563
[TBL] [Abstract][Full Text] [Related]
34. [Clinico-anatomic characteristics of pancreatic cancer].
Samsonov VA; Andreeva RM; Fedorova LA; Nekachalov VV
Arkh Patol; 1995; 57(3):65-7. PubMed ID: 7677587
[TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.
Wang F; Gupta S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1458-63. PubMed ID: 16896032
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.
Basso D; Greco E; Fogar P; Pucci P; Flagiello A; Baldo G; Giunco S; Valerio A; Navaglia F; Zambon CF; Pedrazzoli S; Plebani M
Clin Chim Acta; 2005 Jul; 357(2):184-9. PubMed ID: 15946661
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus in pancreatic cancer: is it a causal relationship?
Katsumichi I; Pour PM
Am J Surg; 2007 Oct; 194(4 Suppl):S71-5. PubMed ID: 17903450
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological aspects of neoplasms in diabetes.
Nicolucci A
Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
[TBL] [Abstract][Full Text] [Related]
39. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study.
Rasi A; Soltani-Arabshahi R; Shahbazi N
Int J Dermatol; 2007 Nov; 46(11):1155-9. PubMed ID: 17988334
[TBL] [Abstract][Full Text] [Related]
40. Preoperative glucose and protein metabolism: the influence of diabetes mellitus type 2 in patients with colorectal tumors.
Lugli AK; Donatelli F; Schricker T; Wykes L; Carli F
Nutr Cancer; 2011; 63(6):924-9. PubMed ID: 21745052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
